Abstract
AB026. Outcomes and toxicities of definitive radiation therapy for unresected thymic malignancies
Mediastinum
2023;
7:
AB026
(30 December 2023)
Abstract
AB025. Evaluation of potential therapeutic immunohistochemical targets with experimental or FDA-approved therapies in thymic epithelial tumor microarrays
Mediastinum
2023;
7:
AB025
(30 December 2023)
Abstract
AB024. Autoimmune and neoplastic comorbidities in patients from the National Danish TET Database
Mediastinum
2023;
7:
AB024
(30 December 2023)
Abstract
AB023. Female patients developing B type thymoma after breast implantation: a report of 6 cases
Mediastinum
2023;
7:
AB023
(30 December 2023)
Abstract
AB021. Incidence, histology, and characteristics of patients from the Danish National TET Database
Mediastinum
2023;
7:
AB021
(30 December 2023)
Abstract
AB020. Clinical significance of PET/CT maximum standardized uptake value in predicting lymph node metastasis of thymic epithelial tumors
Mediastinum
2023;
7:
AB020
(30 December 2023)
Abstract
AB019. Anti-angiogenesis therapy in patients of thymic malignancies with hepatic metastasis
Mediastinum
2023;
7:
AB019
(30 December 2023)
Abstract
AB018. Local recurrence of thymoma following minimally invasive resection: a retrospective case series
Mediastinum
2023;
7:
AB018
(30 December 2023)
Abstract
AB017. Circulating exosomal miRNAs as potential diagnostic and prognostic biomarkers for thymic squamous cell carcinoma
Mediastinum
2023;
7:
AB017
(30 December 2023)
Abstract
AB016. Phase 2 clinical trial of PT-112 in patients with thymic epithelial tumors
Mediastinum
2023;
7:
AB016
(30 December 2023)
Abstract
AB015. Case report: primary adenocarcinoma not otherwise specified of the thymus and cytological features
Mediastinum
2023;
7:
AB015
(30 December 2023)
Abstract
AB014. Bone marrow dyscrasias in autoimmune regulator deficiency: lessons from thymoma and autoimmune polyendocrinopathy-candidiasis ectodermal dystrophy
Mediastinum
2023;
7:
AB014
(30 December 2023)
Abstract
AB013. Occurrence and severity of COVID-19 in patients affected by thymic epithelial tumors with or without Good’s syndrome: a single centre experience
Mediastinum
2023;
7:
AB013
(30 December 2023)
Abstract
AB012. The potential role of innate lymphoid cells in thymic epithelial tumors
Mediastinum
2023;
7:
AB012
(30 December 2023)
Abstract
AB011. Quantification of thymic epithelial tumor volumes through deep learning
Mediastinum
2023;
7:
AB011
(30 December 2023)
Abstract
AB010. Thymoma and T-cell lymphoblastic leukemia/lymphoma: where is the connection?
Mediastinum
2023;
7:
AB010
(30 December 2023)
Abstract
AB009. Spatial proteomic analysis of the human thymic microenvironment shaping T cell development
Mediastinum
2023;
7:
AB009
(30 December 2023)
Abstract
AB008. Results of systemic therapy and surgery for primary mediastinal seminoma
Mediastinum
2023;
7:
AB008
(30 December 2023)
Abstract
AB007. A case of myasthenia gravis, pure red cell aplasia and thymoma, but not in the order you might expect
Mediastinum
2023;
7:
AB007
(30 December 2023)
Abstract
AB006. Atypical morphologies of thymic hyperplasia on CT and MRI
Mediastinum
2023;
7:
AB006
(30 December 2023)
Abstract
AB005. Thymus in focus: radiologically dissecting thymic masses
Mediastinum
2023;
7:
AB005
(30 December 2023)
Abstract
AB004. Basaloid carcinoma of the thymus: experience of the RYTHMIC network over an 8-year period
Mediastinum
2023;
7:
AB004
(30 December 2023)
Abstract
AB003. Unexpected long-lasting control of thymic carcinoma treated with anti-PD1 and oral etoposide: a real-life experience of combination therapy
Mediastinum
2023;
7:
AB003
(30 December 2023)
Abstract
AB002. Prednisone as neoadjuvant therapy in thymomas
Mediastinum
2023;
7:
AB002
(30 December 2023)
Abstract
AB001. A study of the association between thymic malignancy histology and autoimmune paraneoplastic syndromes and opportunistic infections
Mediastinum
2023;
7:
AB001
(30 December 2023)
Disclosure:
The “Abstract Book for the 13th International Thymic Malignancy Interest Group Annual Meeting (ITMIG 2023)” was commissioned by the editorial office, Mediastinum without any sponsorship or funding.